{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T07:26:37Z","timestamp":1745220397362,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013943","name":"CNAM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013943","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13321-016-0154-2","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T02:19:29Z","timestamp":1473128369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores"],"prefix":"10.1186","volume":"8","author":[{"given":"Nathalie","family":"Lagarde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solenne","family":"Delahaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Zagury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-460X","authenticated-orcid":false,"given":"Matthieu","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"issue":"5","key":"154_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1517\/14728222.7.5.679","volume":"7","author":"FM Sladek","year":"2003","unstructured":"Sladek FM (2003) Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areas. Expert Opin Ther Targets 7(5):679\u2013684","journal-title":"Expert Opin Ther Targets"},{"issue":"1\u20132","key":"154_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mce.2010.06.018","volume":"334","author":"FM Sladek","year":"2011","unstructured":"Sladek FM (2011) What are nuclear receptor ligands? Mol Cell Endocrinol 334(1\u20132):3\u201313","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"154_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.cbpa.2008.07.001","volume":"12","author":"T Chen","year":"2008","unstructured":"Chen T (2008) Nuclear receptor drug discovery. Curr Opin Chem Biol 12(4):418\u2013426","journal-title":"Curr Opin Chem Biol"},{"issue":"14","key":"154_CR4","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1021\/jm0300173","volume":"46","author":"M Schapira","year":"2003","unstructured":"Schapira M, Abagyan R, Totrov M (2003) Nuclear hormone receptor targeted virtual screening. J Med Chem 46(14):3045\u20133059","journal-title":"J Med Chem"},{"issue":"4","key":"154_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/bst0300797","volume":"30","author":"J Mestres","year":"2002","unstructured":"Mestres J (2002) Virtual screening: a real screening complement to high-throughput screening. Biochem Soc Trans 30(4):797\u2013799","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"154_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cbpa.2004.06.008","volume":"8","author":"TI Oprea","year":"2004","unstructured":"Oprea TI, Matter H (2004) Integrating virtual screening in lead discovery. Curr Opin Chem Biol 8(4):349\u2013358","journal-title":"Curr Opin Chem Biol"},{"key":"154_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ymeth.2014.07.007","volume":"71","author":"A Kumar","year":"2015","unstructured":"Kumar A, Zhang KY (2015) Hierarchical virtual screening approaches in small molecule drug discovery. Methods 71:26\u201337","journal-title":"Methods"},{"issue":"2","key":"154_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/10629360290002820","volume":"13","author":"P Schmieder","year":"2002","unstructured":"Schmieder P, Koleva Y, Mekenyan O (2002) A reactivity pattern for discrimination of ER agonism and antagonism based on 3-D molecular attributes. SAR QSAR Environ Res 13(2):353\u2013364","journal-title":"SAR QSAR Environ Res"},{"issue":"29","key":"154_CR9","doi-asserted-by":"publisher","first-page":"11927","DOI":"10.1073\/pnas.0609752104","volume":"104","author":"WH Bisson","year":"2007","unstructured":"Bisson WH, Cheltsov AV, Bruey-Sedano N, Lin B, Chen J, Goldberger N et al (2007) Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proc Natl Acad Sci USA 104(29):11927\u201311932","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"154_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.toxlet.2009.08.001","volume":"191","author":"T Nose","year":"2009","unstructured":"Nose T, Tokunaga T, Shimohigashi Y (2009) Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist\/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate. Toxicol Lett 191(1):33\u201339","journal-title":"Toxicol Lett"},{"key":"154_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ejmech.2013.02.015","volume":"63","author":"A Carrieri","year":"2013","unstructured":"Carrieri A, Giudici M, Parente M, De Rosas M, Piemontese L, Fracchiolla G et al (2013) Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha\/gamma agonists. Eur J Med Chem 63:321\u2013332","journal-title":"Eur J Med Chem"},{"issue":"1","key":"154_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.taap.2013.04.032","volume":"272","author":"L Zhang","year":"2013","unstructured":"Zhang L, Sedykh A, Tripathi A, Zhu H, Afantitis A, Mouchlis VD et al (2013) Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches. Toxicol Appl Pharmacol 272(1):67\u201376","journal-title":"Toxicol Appl Pharmacol"},{"key":"154_CR13","doi-asserted-by":"publisher","unstructured":"Ekins S, Goldsmith M-R, Simon A, Zsoldos Z, Ravitz O, Williams AJ (2013) LASSO-ing potential nuclear receptor agonists and antagonists: a new computational method for database screening. J Comput Med 2013:8. doi:\n                    10.1155\/2013\/513537","DOI":"10.1155\/2013\/513537"},{"issue":"4","key":"154_CR14","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1021\/ci400649p","volume":"54","author":"K Kolsek","year":"2014","unstructured":"Kolsek K, Mavri J, Sollner Dolenc M, Gobec S, S Turk (2014) Endocrine disruptome\u2014an open source prediction tool for assessing endocrine disruption potential through nuclear receptor binding. J Chem Inf Model 54(4):1254\u20131267","journal-title":"J Chem Inf Model"},{"issue":"1","key":"154_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.taap.2014.07.009","volume":"280","author":"R Politi","year":"2014","unstructured":"Politi R, Rusyn I, Tropsha A (2014) Prediction of binding affinity and efficacy of thyroid hormone receptor ligands using QSAR and structure-based modeling methods. Toxicol Appl Pharmacol 280(1):177\u2013189","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"154_CR16","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1021\/ci500305c","volume":"54","author":"N Lagarde","year":"2014","unstructured":"Lagarde N, Zagury JF, Montes M (2014) Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands. J Chem Inf Model 54(10):2915\u20132944","journal-title":"J Chem Inf Model"},{"issue":"Suppl 11","key":"154_CR17","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-15-S11-S4","volume":"15","author":"HW Ng","year":"2014","unstructured":"Ng HW, Zhang W, Shu M, Luo H, Ge W, Perkins R et al (2014) Competitive molecular docking approach for predicting estrogen receptor subtype alpha agonists and antagonists. BMC Bioinform 15(Suppl 11):S4","journal-title":"BMC Bioinform"},{"issue":"6652","key":"154_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/39645","volume":"389","author":"AM Brzozowski","year":"1997","unstructured":"Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O et al (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389(6652):753\u2013758","journal-title":"Nature"},{"issue":"3","key":"154_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","volume":"10","author":"D Moras","year":"1998","unstructured":"Moras D, Gronemeyer H (1998) The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10(3):384\u2013391","journal-title":"Curr Opin Cell Biol"},{"key":"154_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev.biochem.68.1.559","volume":"68","author":"RV Weatherman","year":"1999","unstructured":"Weatherman RV, Fletterick RJ, Scanlan TS (1999) Nuclear-receptor ligands and ligand-binding domains. Annu Rev Biochem 68:559\u2013581","journal-title":"Annu Rev Biochem"},{"issue":"10","key":"154_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0165-6147(00)01548-0","volume":"21","author":"W Bourguet","year":"2000","unstructured":"Bourguet W, Germain P, Gronemeyer H (2000) Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 21(10):381\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"154_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0083-6729(00)59007-4","volume":"59","author":"F Bachmair","year":"2000","unstructured":"Bachmair F, Hoffmann R, Daxenbichler G, Langer T (2000) Studies on structure\u2013activity relationships of retinoic acid receptor ligands by means of molecular modeling. Vitam Horm 59:159\u2013215","journal-title":"Vitam Horm"},{"issue":"6","key":"154_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/jm0004749","volume":"44","author":"TA Spencer","year":"2001","unstructured":"Spencer TA, Li D, Russel JS, Collins JL, Bledsoe RK, Consler TG et al (2001) Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha. J Med Chem 44(6):886\u2013897","journal-title":"J Med Chem"},{"issue":"2","key":"154_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1021\/ci049722q","volume":"45","author":"D Schuster","year":"2005","unstructured":"Schuster D, Langer T (2005) The identification of ligand features essential for PXR activation by pharmacophore modeling. J Chem Inf Model 45(2):431\u2013439","journal-title":"J Chem Inf Model"},{"issue":"9","key":"154_CR25","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1021\/ci100511v","volume":"51","author":"W Zhao","year":"2011","unstructured":"Zhao W, Gu Q, Wang L, Ge H, Li J, Xu J (2011) Three-dimensional pharmacophore modeling of liver-X receptor agonists. J Chem Inf Model 51(9):2147\u20132155","journal-title":"J Chem Inf Model"},{"issue":"22","key":"154_CR26","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1016\/j.bmc.2011.09.039","volume":"19","author":"U Grienke","year":"2011","unstructured":"Grienke U, Mihaly-Bison J, Schuster D, Afonyushkin T, Binder M, Guan SH et al (2011) Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum. Bioorg Med Chem 19(22):6779\u20136791","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"154_CR27","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/ci300096c","volume":"52","author":"S Grafenstein von","year":"2012","unstructured":"von Grafenstein S, Mihaly-Bison J, Wolber G, Bochkov VN, Liedl KR, Schuster D (2012) Identification of novel liver X receptor activators by structure-based modeling. J Chem Inf Model 52(5):1391\u20131400","journal-title":"J Chem Inf Model"},{"issue":"2","key":"154_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1021\/ci400682b","volume":"54","author":"V Temml","year":"2014","unstructured":"Temml V, Voss CV, Dirsch VM, Schuster D (2014) Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening. J Chem Inf Model 54(2):367\u2013371","journal-title":"J Chem Inf Model"},{"key":"154_CR29","doi-asserted-by":"publisher","unstructured":"Teske K, Nandhikonda P, Bogart JW, Feleke B, Sidhu P, Yuan N et al (2014) Identification of Vdr antagonists among nuclear receptor ligands using virtual screening. Nucl Recept Res. doi:\n                    10.11131\/2014\/101076","DOI":"10.11131\/2014\/101076"},{"issue":"5","key":"154_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10822-015-9831-x","volume":"29","author":"SN Lewis","year":"2015","unstructured":"Lewis SN, Garcia Z, Hontecillas R, Bassaganya-Riera J, Bevan DR (2015) Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands. J Comput Aided Mol Des 29(5):421\u2013439","journal-title":"J Comput Aided Mol Des"},{"issue":"3","key":"154_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ddtec.2004.11.015","volume":"1","author":"T Langer","year":"2004","unstructured":"Langer T, Wolber G (2004) Pharmacophore definition and 3D searches. Drug Discov Today Technol 1(3):203\u2013207","journal-title":"Drug Discov Today Technol"},{"issue":"4","key":"154_CR32","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.ddtec.2010.11.004","volume":"7","author":"T Seidel","year":"2010","unstructured":"Seidel T, Ibis G, Bendix F, Wolber G (2010) Strategies for 3D pharmacophore-based virtual screening. Drug Discov Today Technol 7(4):e221\u2013e228","journal-title":"Drug Discov Today Technol"},{"issue":"7","key":"154_CR33","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1021\/jm500132p","volume":"57","author":"N Lagarde","year":"2014","unstructured":"Lagarde N, Ben Nasr N, Jeremie A, Guillemain H, Laville V, Labib T et al (2014) NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database. J Med Chem 57(7):3117\u20133125","journal-title":"J Med Chem"},{"issue":"1","key":"154_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45(1):160\u2013169","journal-title":"J Chem Inf Model"},{"key":"154_CR35","first-page":"253","volume-title":"Pharmacophores and pharmacophore searches","author":"F Manetti","year":"2006","unstructured":"Manetti F, Botta M, Tafi A (2006) Application of pharmacophore models in medicinal chemistry. In: Langer T, Hoffmann RD (eds) Pharmacophores and pharmacophore searches, vol 32. WILEY-VCH, Weinheim, pp 253\u2013282"},{"key":"154_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1039\/9781847558879-00076","volume-title":"Chemoinformatics approaches to virtual screening","author":"C Laggner","year":"2008","unstructured":"Laggner C, Wolber G, Kirchmair J, Schuster D, Langer T (2008) Pharmacophore-based virtual screening in drug discovery. In: Varnek A, Tropsha A (eds) Chemoinformatics approaches to virtual screening. Royal Society of Chemistry, London, pp 76\u2013119"},{"issue":"12","key":"154_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s10822-006-9078-7","volume":"20","author":"G Wolber","year":"2006","unstructured":"Wolber G, Dornhofer AA, Langer T (2006) Efficient overlay of small organic molecules using 3D pharmacophores. J Comput Aided Mol Des 20(12):773\u2013788","journal-title":"J Comput Aided Mol Des"},{"key":"154_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ymeth.2014.10.013","volume":"71","author":"A Vuorinen","year":"2015","unstructured":"Vuorinen A, Schuster D (2015) Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling. Methods 71:113\u2013134","journal-title":"Methods"},{"key":"154_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/minf.201300063","volume":"33","author":"A Vuorinen","year":"2014","unstructured":"Vuorinen A, Nashev LG, Odermatt A, Rollinger JM, Schuster D (2014) Pharmacophore model refinement for 11\u03b2-hydroxysteroid dehydrogenase inhibitors: search for modulators of intracellular glucocorticoid concentrations. Mol Inform 33:15\u201325","journal-title":"Mol Inform"},{"issue":"12","key":"154_CR40","doi-asserted-by":"publisher","first-page":"22799","DOI":"10.3390\/molecules201219880","volume":"20","author":"T Kaserer","year":"2015","unstructured":"Kaserer T, Beck KR, Akram M, Odermatt A, Schuster D (2015) Pharmacophore models and pharmacophore-based virtual screening: concepts and applications exemplified on hydroxysteroid dehydrogenases. Molecules 20(12):22799\u201322832","journal-title":"Molecules"},{"issue":"1","key":"154_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/ci8003607","volume":"49","author":"A Kumar","year":"2009","unstructured":"Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI (2009) Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints. J Chem Inf Model 49(1):35\u201342","journal-title":"J Chem Inf Model"},{"issue":"6","key":"154_CR42","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1021\/jm901798e","volume":"53","author":"X Liu","year":"2010","unstructured":"Liu X, Xie H, Luo C, Tong L, Wang Y, Peng T et al (2010) Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening. J Med Chem 53(6):2661\u20132665","journal-title":"J Med Chem"},{"issue":"4","key":"154_CR43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1021\/ci9004173","volume":"50","author":"Z Chen","year":"2010","unstructured":"Chen Z, Tian G, Wang Z, Jiang H, Shen J, Zhu W (2010) Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity. J Chem Inf Model 50(4):615\u2013625","journal-title":"J Chem Inf Model"},{"key":"154_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmgm.2012.03.004","volume":"36","author":"L Di-wu","year":"2012","unstructured":"Di-wu L, Li LL, Wang WJ, Xie HZ, Yang J, Zhang CH et al (2012) Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking. J Mol Graph Model 36:42\u201347","journal-title":"J Mol Graph Model"},{"issue":"3","key":"154_CR45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1021\/ci400742s","volume":"54","author":"M Gabrielsen","year":"2014","unstructured":"Gabrielsen M, Kurczab R, Siwek A, Wolak M, Ravna AW, Kristiansen K et al (2014) Identification of novel serotonin transporter compounds by virtual screening. J Chem Inf Model 54(3):933\u2013943","journal-title":"J Chem Inf Model"},{"issue":"1","key":"154_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1182\/blood-2013-05-503227","volume":"123","author":"GA Nicolaes","year":"2014","unstructured":"Nicolaes GA, Kulharia M, Voorberg J, Kaijen PH, Wroblewska A, Wielders S et al (2014) Rational design of small molecules targeting the C2 domain of coagulation factor VIII. Blood 123(1):113\u2013120","journal-title":"Blood"},{"issue":"7","key":"154_CR47","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/aps.2014.34","volume":"35","author":"MM Niu","year":"2014","unstructured":"Niu MM, Qin JY, Tian CP, Yan XF, Dong FG, Cheng ZQ et al (2014) Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking. Acta Pharmacol Sin 35(7):967\u2013979","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"154_CR48","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1021\/ci500114r","volume":"54","author":"Q Wang","year":"2014","unstructured":"Wang Q, Park J, Devkota AK, Cho EJ, Dalby KN, Ren P (2014) Identification and validation of novel PERK inhibitors. J Chem Inf Model 54(5):1467\u20131475","journal-title":"J Chem Inf Model"},{"issue":"3","key":"154_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1021\/acs.jcim.5b00658","volume":"56","author":"T Kaserer","year":"2016","unstructured":"Kaserer T, Rigo R, Schuster P, Alcaro S, Sissi C, Schuster D (2016) Optimized virtual screening workflow for the identification of novel G-quadruplex ligands. J Chem Inf Model 56(3):484\u2013500","journal-title":"J Chem Inf Model"},{"issue":"12","key":"154_CR50","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1021\/cb400521b","volume":"8","author":"RM Vitale","year":"2013","unstructured":"Vitale RM, Gatti M, Carbone M, Barbieri F, Felicita V, Gavagnin M et al (2013) Minimalist hybrid ligand\/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of phidianidine a as a new CXCR4 ligand exhibiting antagonist activity. ACS Chem Biol 8(12):2762\u20132770","journal-title":"ACS Chem Biol"},{"key":"154_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jmgm.2014.01.002","volume":"49","author":"RP Gangwal","year":"2014","unstructured":"Gangwal RP, Das NR, Thanki K, Damre MV, Dhoke GV, Sharma SS et al (2014) Identification of p38alpha MAP kinase inhibitors by pharmacophore based virtual screening. J Mol Graph Model 49:18\u201324","journal-title":"J Mol Graph Model"},{"key":"154_CR52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12688\/f1000research.5741.1","volume":"3","author":"S Ekins","year":"2014","unstructured":"Ekins S, Freundlich JS, Coffee M (2014) A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus. F1000Research 3:277","journal-title":"F1000Research"},{"issue":"24","key":"154_CR53","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1016\/j.bmcl.2014.10.042","volume":"24","author":"B Pogorelcnik","year":"2014","unstructured":"Pogorelcnik B, Brvar M, Zajc I, Filipic M, Solmajer T, Perdih A (2014) Monocyclic 4-amino-6-(phenylamino)-1,3,5-triazines as inhibitors of human DNA topoisomerase IIalpha. Bioorg Med Chem Lett 24(24):5762\u20135768","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"154_CR54","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1021\/ci100136b","volume":"50","author":"GM Spitzer","year":"2010","unstructured":"Spitzer GM, Heiss M, Mangold M, Markt P, Kirchmair J, Wolber G et al (2010) One concept, three implementations of 3D pharmacophore-based virtual screening: distinct coverage of chemical search space. J Chem Inf Model 50(7):1241\u20131247","journal-title":"J Chem Inf Model"},{"issue":"6","key":"154_CR55","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1021\/ci2005274","volume":"52","author":"MP Sanders","year":"2012","unstructured":"Sanders MP, Barbosa AJ, Zarzycka B, Nicolaes GA, Klomp JP, de Vlieg J et al (2012) Comparative analysis of pharmacophore screening tools. J Chem Inf Model 52(6):1607\u20131620","journal-title":"J Chem Inf Model"},{"issue":"17","key":"154_CR56","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.4155\/fmc.14.114","volume":"6","author":"V Temml","year":"2014","unstructured":"Temml V, Kaserer T, Kutil Z, Landa P, Vanek T, Schuster D (2014) Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio. Future Med Chem 6(17):1869\u20131881","journal-title":"Future Med Chem"},{"issue":"12","key":"154_CR57","doi-asserted-by":"publisher","first-page":"e84510","DOI":"10.1371\/journal.pone.0084510","volume":"8","author":"D Warszycki","year":"2013","unstructured":"Warszycki D, Mordalski S, Kristiansen K, Kafel R, Sylte I, Chilmonczyk Z et al (2013) A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds\u2014an application for 5-HT1A receptor ligands. PLoS One 8(12):e84510","journal-title":"PLoS One"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-016-0154-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-016-0154-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-016-0154-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T04:37:45Z","timestamp":1589690265000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-016-0154-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["154"],"URL":"https:\/\/doi.org\/10.1186\/s13321-016-0154-2","relation":{},"ISSN":["1758-2946"],"issn-type":[{"type":"electronic","value":"1758-2946"}],"subject":[],"published":{"date-parts":[[2016,9,6]]},"assertion":[{"value":"24 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"43"}}